Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing aripiprazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 10 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Product containing precisely aripiprazole 15 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 20 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 30 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Product containing aripiprazole in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 7.5mg/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole lauroxil (substance) |
Is a |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 30 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 15 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole lauroxil (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
|
Aripiprazole 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Product containing only aripiprazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Product containing only aripiprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 10 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 10 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 20 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 20 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aripiprazole 15 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aripiprazole 15 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 30 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 30 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 7.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole 7.5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Aripiprazole only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |
Product containing aripiprazole in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aripiprazole (substance) |
Inferred relationship |
Some |
1 |